Your session is about to expire
← Back to Search
Other
Hyperbaric Oxygen Therapy- for Urinary Tract Infection (HBOTCICrUTI Trial)
Phase < 1
Waitlist Available
Led By Ian R Grover, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three year study period. determination of this endpoint will be made for each individual patient at one year after final hbot session.
Awards & highlights
HBOTCICrUTI Trial Summary
This trial will test if a known treatment for one inflammatory bladder condition can be effective for two other similar conditions, with the goal of helping patients who presently have few options.
Eligible Conditions
- Urinary Tract Infection
- Interstitial Cystitis
HBOTCICrUTI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ three year study period. determination is made for this endpoint on the date of final hbot session.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three year study period. determination is made for this endpoint on the date of final hbot session.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
HBOT acceptance
HBOT adherence
Secondary outcome measures
Post treatment incidence of recurrent urinary tract infection.
Interstitial Cystitis
Pre and post treatment symptom survey fro the chronic interstitial cystitis study group. The patient's overall rating of improvement of symptoms (PORIS) will be used.
+1 moreHBOTCICrUTI Trial Design
1Treatment groups
Experimental Treatment
Group I: Hyperbaric OxygenExperimental Treatment1 Intervention
Hyperbaric oxygen therapy-2.4 atmosphere absolute for 90 minutes with 2-five minute air breaks administered daily, 5 days per week for 8 weeks total treatment.
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,396 Total Patients Enrolled
2 Trials studying Urinary Tract Infection
410 Patients Enrolled for Urinary Tract Infection
Ian R Grover, MDPrincipal InvestigatorUniversity of California, San Diego
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger